EDGAR Filing Documents for 0001493152-24-023481

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-24-023481

Filing Date

2024-06-11

Accepted

2024-06-11 16:28:30

Documents

Period of Report

2024-03-31

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm iXBRL	10-Q	682554
2		ex31-1.htm	EX-31.1	16019
3		ex31-2.htm	EX-31.2	15917
4		ex32-1.htm	EX-32.1	7908
	Complete submission text file	0001493152-24-023481.txt		3968355

Data Files

Seq	Description	Document	Type	Size
5	XBRL SCHEMA FILE	brtx-20240331.xsd	EX-101.SCH	29766
6	XBRL CALCULATION FILE	brtx-20240331_cal.xml	EX-101.CAL	42532
7	XBRL DEFINITION FILE	brtx-20240331_def.xml	EX-101.DEF	136592
8	XBRL LABEL FILE	brtx-20240331_lab.xml	EX-101.LAB	280282
9	XBRL PRESENTATION FILE	brtx-20240331_pre.xml	EX-101.PRE	221937
58	EXTRACTED XBRL INSTANCE DOCUMENT	form10-q_htm.xml	XML	561662

Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747

Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100

BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 301341024 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37603 | Film No.: 241036170
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)